Small, private companies may be able to progress development of their compounds or technologies up to a point, but are very unlikely to be able to commercialise pharmaceutical products on their own on a worldwide basis, as they will not be able to set up the infrastructure for marketing and distribution. As a result, the vast majority of biotech companies will need corporate deals with pharma companies that have the means to commercialise on a large scale and around the world.
We are a science and medicine-driven healthcare advisory UK company based in London, with an international network.
Our focus is on providing support in Business Development & Licensing deals, Product Development and Financing.
[remove spaces between words]